Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Maternity
  4. Back
  5. Medical conditions in pregnancy - diabetes
  6. Diabetes, continuous subcutaneous insulin infusion (CSII) in labour: Protocol for patient self management (521)
Announcements and latest updates

Right Decision Service newsletter: September 2024

Welcome to the Right Decision Service (RDS) newsletter for September 2024.

1.Business case for permanent provision of the Right Decision Service from April 2025 onwards

This business case has now been endorsed by the HIS Board and will shortly be submitted to Scottish Government.

2. Management of RDS support tickets

To balance increasing demand with available capacity and financial resource, the RDS team and Tactuum are now working together to  implement closer management of support tickets. As a key part of this, we want to ensure clear, timely and consistent communication with yourselves as requesters.  

Editors will now start seeing new messages come through in response to support ticket requests which reflect this tightening up and improvement of our processes.

Key points to note are:

2.1 Issues confirmed by the RDS and Tactuum teams as meeting the critical/urgent and high priority criteria will continue to be prioritised and dealt with immediately.

Critical/urgent issues are defined as:

  1. The Service as a whole is not operational for multiple users. OR
  2. Multiple core functions of the Service are not operational for multiple users.

Example – RDS website outage.

Please remember to email ann.wales3@nhs.scot and his.decisionsupport@nhs.scot with any critical/urgent issues in addition to raising a support ticket.

High priority issues are defined as:

  1. A single core function of the Service is not operational for multiple users. OR:
  2. Multiple non-core functions of the Service are not operational for multiple users.

Example – Build to app not working.

2.2 Support requests that are outwith the warranty period of 12 weeks since the software was originally developed will not be automatically addressed by Tactuum. The RDS team will consider these requests for costed development work and will obtain estimate of effort and cost from Tactuum for priority issues.

2.3 Support tickets for technical issues that are not classified as bugs will not be automatically addressed by Tactuum. The definition of a bug is ‘a defect in the software that is at variance with documented user requirements.’  Issues that are not bugs will also be considered for costed development work.

The majority of issues currently in support tickets fall into category 2 or 3 above, or both.

2.4 Non-urgent requests that require a deployment (i.e a new release of RDS) will normally be factored into the next scheduled release (currently end of Nov 2024 and end of Feb 2025) unless by special agreement with the RDS team.

Please note that we plan to move in the new year to a new system whereby requests all come to an RDS support portal in the first instance and are triaged from there to Tactuum when appropriate.

We will be organising a webinar in a few weeks’ time to take you through the details of the current support processes and criteria.

3. Next scheduled deployment.

The next scheduled RDS deployment will take place at the end of November 2024.  We are reviewing all outstanding support tickets and feature requests along with estimates of effort and cost to determine which items will be included in this deployment.

We will update you on this in the next newsletter and in the planned webinar about support ticket processes.

4. Contingency arrangements for RDS

Many thanks to those of you who attended our recent webinar on the contingency arrangements being put in place to prevent future RDS outages as far as possible and minimise impact if they do occur.  Please contact ann.wales3@nhs.scot if you would like a copy of the slides from this session.

5. Transfer of CKP pathways to RDS

The NES clinical knowledge pathway (CKP) publisher is now retired and the majority of pathways supported by this tool have been transferred to the RDS. Examples include:

NHS Lothian musculoskeletal pathways

NHS Fife rehabilitation musculoskeletal pathways

NHS Tayside paediatric pathways

6. Other new RDS toolkits

Include:

Focus on frailty (from HIS Frailty improvement programme)

NHS GGC Money advice and support

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

To go live imminently:

  • Focus on dementia
  • NHS Lothian infectious diseases toolkit
  • Dumfries and Galloway Adult Support and Protection procedures
  • SIGN guideline – Prevention and remission of type 2 diabetes

 

7. Evaluation projects

We have recently analysed the results of a survey of users of the Scottish Palliative Care Guidelines toolkit.  Key findings from 61 respondents include:

  • Most respondents (64%) are frequent users of the toolkit, using it either daily or weekly. A further 25% use it once or twice per month.
  • 5% of respondents use the toolkit to deliver direct patient care and 82% use it for learning
  • Impact on practice and decision-making was rated as very high, with 80% of respondents rating these at a 4-5 on a 5 point scale.
  • Impact on time saving was also high, with 74% of respondents rating it from 3-5.
  • 74% also reported that the toolkit improved their knowledge and skills, rating these at 4-5 on the Likert scale

Key strengths identified included:

  • The information is useful, succinct, and easy to understand (31%).
  • Coverage is comprehensive (15%)
  • All information is readily accessible in one place and users value the offline access via mobile app (15%)
  • Information is reliable, evidence-based and up to date (13%)

Users highlighted key areas for improvement in terms of navigation and search functionality. The survey was very valuable in enabling us to uncover the specific issues affecting the user experience. Many of these can be addressed through content management approaches. The issues identified with search results echo other user feedback, and we are costing improvements with a view to implementation in the next RDS deployment.

8.RDS High risk prescribing (polypharmacy) decision support embedded in Vision and EMIS primary care E H R systems

This decision support software, sponsored by Scottish Government Effective Prescribing and Therapeutics Division,  is now available for all primary care clinicians across NHS Tayside. Board-wide implementation is also planned for NHS Lothian, and NHS GGC, NHS Ayrshire and Arran and NHS Dumfries and Galloway have initial pilots in progress. The University of Dundee has been commissioned to evaluate impact of this decision support software on prescribing practice.

9. Video tutorials for RDS editors

Ten bite-size (5 mins or less) video tutorials for RDS editors are now available in the “Resources for providers of RDS tools” section of the RDS.  These cover core functionality including Save and preview, content page and media management, password management and much more.

10. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Wednesday 23rd October 4-5 pm
  • Tuesday 29th October 11 am -12 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

 

Diabetes, continuous subcutaneous insulin infusion (CSII) in labour: Protocol for patient self management (521)

Warning

Please report any inaccuracies or issues with this guideline using our online form

General notes

This protocol is for women who choose to continue to use their insulin pump (CSII) in labour.

Women following this guideline must be aware that clinical staff will NOT adjust settings on pump and that they will not advise of setting changes outwith those discussed in this guideline.

Women must be aware that wishes to continue pump will be taken seriously but there is a need to be flexible with clinical recommendations.

IF AT ANY POINT THE WOMAN BECOMES UNABLE TO MANAGE THE DEVICE THEN THEY SHOULD BE SWITCHED TO INTRAVENOUS INSULIN AND THE PUMP STOPPED. IT IS NOT APPROPRIATE FOR MIDWIFERY STAFF OR BIRTH PARTNERS TO ADJUST THE INSULIN PUMP.

Caesarean Section

There is a risk that diathermy will interfere with the insulin pump settings. 

For women undergoing Caesarean section the pump should be disconnected from the infusion set prior to the procedure, and IV insulin infusion as per guideline should be established. The infusion set can be left in situ.

Following delivery the pump can be re-connected to the infusion set. Insulin settings after delivery are 50-75% of the pre-pregnancy doses (see below) 

Equipment

All women should have

  • 2 x Spare set of batteries
  • 2 x reservoirs
  • 5 x infusion sets including lines (and inserter device)
  • Back-up insulin pens (long and short acting insulin)

At onset of labour (0-4cm) – NB: many women will be at home

  • Woman should ensure:
    • New batteries inserted into pump
    • Fill a new reservoir with insulin
    • Put in a complete new infusion set (including line)
    • Locate the infusion site below rib cage and towards back so that it will not interfere with emergency intervention
  • Continue current basal rates and bolus ratios.
  • Pregnant woman or midwife should check capillary blood glucose (CBG) 2 hourly or sooner if symptomatic of hypoglycemia
  • Pregnant woman should treat hypoglycaemia as she would if not in labour
  • If more than 2 hypoglycemic events during the initial stage of labour, then woman should reduce all basal rates by 50%
  • If CBG > 10 mmol/l then check ketones and give a correction dose as per sensitivity (see guidance below)

Active labour (4cm-delivery)

  • IV access should be obtained in case of need for IV insulin therapy or treatment of severe hypoglycemia
  • Basal insulin should continue at current rates
  • Women are not usually advised to eat/drink during this stage but if they do, then bolus insulin ratio should be given at the same ratios as before labour.
  • Blood glucose monitoring should be taken hourly by pregnant woman/clinical team and recorded by clinical team (using the insulin sliding scale in labour chart)

  • If CBG < 4 mmol/l, then treat the hypoglycaemia as normal (may require IV glucose if strictly NBM)
  • If CBG < 4 mmol/l on more than one occasion, then reduce basal rate further by 50%
  • If CBG >10 mmol/l
    • Check for ketones
    • If ketones positive then start IV insulin sliding scale with fluids immediately, with insulin pump continuing in background
    • If ketone negative give correction dose as per below sensitivity and recheck in 1 hour
    • If CBG not falling repeat this step and recheck CBG after 1 hour
    • If CBG rising despite correction dose or not coming down after 2 correction doses then start IV insulin infusion (continue pump in background and perform set change)

Immediately (within 30 minutes) after delivery:

  • Immediately following delivery of placenta, the basal rates on pump should be set to 50-75% of pre-pregnancy rates and bolus ratios should also be administered at 50-75% of prepregnancy doses. These should be prescribed on attached sheet and discussed with the woman.
  • If the pre-pregnancy rates are not known, the diabetes team should advise what basal rates should be set to and bolus ratio should start at 1 unit for 20g carbohydrate.
  • Women on CSII are usually very comfortable managing their diabetes and should not be discouraged from adjusting their own settings Review by diabetes team within 24-48 hours of delivery

IF AT ANY POINT THE WOMAN BECOMES UNABLE TO MANAGE THE DEVICE THEN A SWITCH TO INTRAVENOUS INSULIN SHOULD TAKE PLACE AND THE PUMP STOPPED.

IF AT ANY POINT THE WOMAN BECOMES UNABLE TO MANAGE THE DEVICE THEN A SWITCH TOINTRAVENOUS INSULIN SHOULD TAKE PLACE AND THE PUMP STOPPED.

List not exhaustive but may include:

  • Pregnant woman too distressed or uncomfortable to manage the pump
  • Complications with clinical staff feeling that the more familiar IV insulin therapy be commenced instead – please discuss with woman
  • Erratic blood sugars with multiple adjustments required during labour
  • Requirement for Caesarean Section

Insulin prescription as suggested by Diabetes team

Patient

CHI

Diabetes type

PRE-LABOUR/EARLY LABOUR

basal rates:

bolus ratio:

Correction e.g. 1 unit will correct by 3 mmol/l:

ACTIVE LABOUR (4cm dilatation-delivery)

Basal rates:    

 bolus ratio:

Correction doses e.g. 1 unit will correct by how many mmol/l:

FIRST 24-48 HOURS POST-DELIVERY OF PLACENTA:

Basal rates:       

 bolus ratio:

Correction doses e.g. 1 unit will correct by how many mmol/l:

Back-up Insulin pens- insulin type and dose. 

Diabetes StR/Consultant should review within 24-48 hours of delivery to advise on further dose adjustment.

Editorial Information

Last reviewed: 26/04/2018

Next review date: 01/03/2022

Author(s): David Carty.

Version: 2

Approved By: Obstetrics Clinical Governance Group

Document Id: 521